Lymphocytic variant hypereosinophilic syndrome successfully treated with hematopoietic stem cell transplantation: A treatment challenge.

Pediatric Blood & CancerEarly View e30698 LETTER TO THE EDITOR Lymphocytic variant hypereosinophilic syndrome successfully treated with hematopoietic stem cell transplantation: A treatment challenge Elena Sebastián, Corresponding Author Elena Sebastián [email protected] orcid.org/0000-0002-5444-8076 Onco-Hematology Department, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Madrid, Spain Correspondence Elena Sebastián, Onco-Hematology Department, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Avenida Menéndez Pelayo, 65, 28009 Madrid, Spain. Email: [email protected]Search for more papers by this authorLaura Andrés-Zallo, Laura Andrés-Zallo orcid.org/0000-0001-9526-2625 Oncology Department, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu, Barcelona, SpainSearch for more papers by this authorMarta González-Vicent, Marta González-Vicent orcid.org/0000-0002-4845-5616 Onco-Hematology Department, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Madrid, SpainSearch for more papers by this authorMaría Jara, María Jara DNA Sequencing Service (NUCLEUS), University of Salamanca, Salamanca, Spain Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, SpainSearch for more papers by this authorBlanca Molina, Blanca Molina orcid.org/0000-0001-9382-8031 Onco-Hematology Department, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Madrid, SpainSearch for more papers by this authorJosune Zubicaray, Josune Zubicaray Onco-Hematology Department, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Madrid, SpainSearch for more papers by this authorEva Gálvez, Eva Gálvez Hematology Department, Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, SpainSearch for more papers by this authorAlberto Orfao, Alberto Orfao Cancer Research Center (IBMCC, CSIC - University of Salamanca), Department of Medicine, Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, SpainSearch for more papers by this authorJulián Sevilla, Julián Sevilla orcid.org/0000-0002-6852-1860 Onco-Hematology Department, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Madrid, SpainSearch for more papers by this author Elena Sebastián, Corresponding Author Elena Sebastián [email protected] orcid.org/0000-0002-5444-8076 Onco-Hematology Department, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Madrid, Spain Correspondence Elena Sebastián, Onco-Hematology Department, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Avenida Menéndez Pelayo, 65, 28009 Madrid, Spain. Email: [email protected]Search for more papers by this authorLaura Andrés-Zallo, Laura Andrés-Zallo orcid.org/0000-0001-9526-2625 Oncology Department, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu, Barcelona, SpainSearch for more papers by this authorMarta González-Vicent, Marta González-Vicent orcid.org/0000-0002-4845-5616 Onco-Hematology Department, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Madrid, SpainSearch for more papers by this authorMaría Jara, María Jara DNA Sequencing Service (NUCLEUS), University of Salamanca, Salamanca, Spain Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, SpainSearch for more papers by this authorBlanca Molina, Blanca Molina orcid.org/0000-0001-9382-8031 Onco-Hematology Department, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Madrid, SpainSearch for more papers by this authorJosune Zubicaray, Josune Zubicaray Onco-Hematology Department, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Madrid, SpainSearch for more papers by this authorEva Gálvez, Eva Gálvez Hematology Department, Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, SpainSearch for more papers by this authorAlberto Orfao, Alberto Orfao Cancer Research Center (IBMCC, CSIC - University of Salamanca), Department of Medicine, Cytometry Service, NUCLEUS, University of Salamanca (Universidad de Salamanca), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, SpainSearch for more papers by this authorJulián Sevilla, Julián Sevilla orcid.org/0000-0002-6852-1860 Onco-Hematology Department, Hospital Infantil Universitario Niño Jesús, Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús, Madrid, SpainSearch for more papers by this author First published: 29 September 2023 https://doi.org/10.1002/pbc.30698Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022; 97(1): 129-148. doi:10.1002/ajh.26352 2Requena G, van den Bosch J, Akuthota P, et al. Clinical profile and treatment in hypereosinophilic syndrome variants: a pragmatic review. J Allergy Clin Immunol Pract. 2022; 10(8): 2125-2134. doi:10.1016/j.jaip.2022.03.034 3Hanbali A, Shaheen M, Alfraih F, et al. A case of T-cell lymphoproliferative disorder associated with hypereosinophilia with excellent response to mycophenolate mofetil. Hematol Oncol Stem Cell Ther. 2018; 11(4): 241-244. doi:10.1016/j.hemonc.2016.11.001 4Klion A. Hypereosinophilic syndrome: approach to treatment in the era of precision medicine. Hematology Am Soc Hematol Educ Program. 2018; 2018(1): 326-331. doi:10.1182/asheducation-2018.1.326 Early ViewOnline Version of Record before inclusion in an issuee30698 ReferencesRelatedInformation